Atlas Trials

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

Clinical trial NCT06965829 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06965829
Sponsor
Shanghai Chest Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer Stage III
Start date
2025-07-01
Primary completion
2028-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.